Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

BACKGROUND: Cancer and its treatment lead to increased financial distress for patients. To the authors' knowledge, to date, no standardized patient‐reported outcome measure has been validated to assess this distress. METHODS: Patients with AJCC Stage IV solid tumors receiving chemotherapy for a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Jonas A., Yap, Bonnie J., Wroblewski, Kristen, Blinder, Victoria, Araújo, Fabiana S., Hlubocky, Fay J., Nicholas, Lauren H., O'Connor, Jeremy M., Brockstein, Bruce, Ratain, Mark J., Daugherty, Christopher K., Cella, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298039/
https://www.ncbi.nlm.nih.gov/pubmed/27716900
http://dx.doi.org/10.1002/cncr.30369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298039/
https://www.ncbi.nlm.nih.gov/pubmed/27716900
http://dx.doi.org/10.1002/cncr.30369

Ejemplares similares